Orlistat
Orlistat is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake. Orlistat works by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. Without this enzyme, triglycerides from the diet are prevented from being hydrolyzed into absorbable free fatty acids and are excreted undigested.
Product Specifications
CAS Number
96829-58-2
Product Name Alternative
Tetrahydrolipstatin
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
Ethanol: 99 mg/mL (199.7 mM) ; DMSO: 99 mg/mL (199.7 mM)
Smiles
CC (C) C[C@H] (NC=O) C (O[C@@H] (CCCCCCCCCCC) C[C@@H] ([C@@H]1CCCCCC) OC1=O) =O
Molecular Formula
C29H53NO5
Molecular Weight
495.73
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
[ (2S) -1-[ (2S,3S) -3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S) -2-formamido-4-methylpentanoate
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Iron Regulatory Protein (IRP-1) (Not for Export EU)
Human Primary Lymphatic Vessel Fibroblasts Cells
Lentiviral human KCTD4 shRNA (UAS) - Lentiviral human KCTD4 shRNA (UAS, GFP) (100)
Recombinant Human DPY30 domain-containing protein 2